MeiraGTx Holdings plc MGTX
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-06-08
MeiraGTx Holdings plc statistics & valuation
Market cap$1.1B
P / S13.8×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2025 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|---|
| Operating margin | -130.2% | — | — | -493.4% | -977.8% |
| Net margin | -140.3% | — | — | -444.1% | -599.5% |
| FCF margin | -61.7% | — | — | -328.9% | -895.6% |
| Return on assets | -46.7% | — | — | -54.8% | -25.7% |
| Return on equity | 1971.4% | — | — | -217.9% | -60.8% |
| Current ratio | 0.75 | 0.22 | 0.88 | 2.03 | 2.38 |
| Revenue growth | — | — | — | 137.4% | -12.0% |
Source: SEC EDGAR filings · CIK 0001735438 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.